Skin Enzymes – Friday Pop Quiz 8/19/2022
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
…
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Everyday Health recently posted an article about the benefits of combined dermatology and rheumatology clinics in the treatment of psoriatic arthritis. Does research show a patient care benefit? What are ways dermatology and rheumatology providers can work better together outside of a combined clinic model?
For expert advice, I reached out to Brad Glick, DO, MPH, clinical assistant professor … 
What sports would be okay for this 14 year old to participate in?
A. Swimming
B. Boxing
C. Football
D. Soccer
E. Hockey
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Atopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (a board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about the latest with JAK inhibitors. Watch as he summarizes the most recent trials, approvals, and developments. Plus why doctors shouldn't be afraid to dive in w … 